BAVETTA, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 749
EU - Europa 173
AS - Asia 76
AF - Africa 6
OC - Oceania 3
Totale 1.007
Nazione #
US - Stati Uniti d'America 746
IT - Italia 70
CN - Cina 45
FI - Finlandia 23
SG - Singapore 22
DE - Germania 21
BE - Belgio 11
IE - Irlanda 11
RO - Romania 10
GB - Regno Unito 8
RU - Federazione Russa 8
CI - Costa d'Avorio 6
UA - Ucraina 4
AU - Australia 3
CA - Canada 3
IR - Iran 3
HK - Hong Kong 2
SE - Svezia 2
BY - Bielorussia 1
CH - Svizzera 1
ES - Italia 1
IL - Israele 1
IN - India 1
KR - Corea 1
LT - Lituania 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.007
Città #
Fairfield 117
Chandler 71
Ashburn 68
Woodbridge 58
Cambridge 53
Wilmington 52
Houston 50
Ann Arbor 49
Seattle 47
Des Moines 30
Palermo 21
Singapore 20
Medford 13
Altamura 11
Brussels 11
Dublin 11
Nanjing 11
New York 10
Lawrence 8
Princeton 8
Abidjan 6
San Diego 6
Boardman 5
Redwood City 5
Beijing 4
Rome 4
Ancona 3
Changsha 3
Hebei 3
Nürnberg 3
Ottawa 3
Phoenix 3
Santa Clara 3
Taizhou 3
Tehran 3
Tulsa 3
Berlin 2
Dearborn 2
Helsinki 2
Hong Kong 2
Hounslow 2
Jiaxing 2
Jinan 2
London 2
Los Angeles 2
Ludwigshafen am Rhein 2
Nanchang 2
Ningbo 2
Saint Petersburg 2
Shenyang 2
Signa 2
Zhengzhou 2
Chicago 1
Columbus 1
Easton 1
Fuzhou 1
Guangzhou 1
Kumar 1
Melbourne 1
Moscow 1
Munich 1
Norwalk 1
Nuremberg 1
Orange 1
Perth 1
Piscataway 1
Radeberg 1
San Francisco 1
Taipei 1
Taiyuan 1
Tel Aviv 1
Torregrotta 1
Venice 1
Verona 1
Washington 1
Zurich 1
Totale 835
Nome #
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 170
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 164
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis 154
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 152
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance 141
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 139
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 68
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis 68
Totale 1.056
Categoria #
all - tutte 3.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 0 0 0 0 32 33 27 21 25 14 17 6
2020/2021155 10 9 5 6 3 5 3 20 28 35 14 17
2021/2022112 2 31 4 6 4 3 8 11 5 11 10 17
2022/2023207 19 41 3 21 20 34 23 10 19 1 13 3
2023/202474 2 8 7 7 10 19 7 4 0 2 1 7
2024/202537 5 6 4 17 5 0 0 0 0 0 0 0
Totale 1.056